Primary record
Sufentanil Citrate; N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- 库存
- 1,445 克
- 纯度
- 98.5 %
- CAS
- 60561-17-3
化合物标识与属性
- CAS
- 60561-17-3
- PubChem CID
- 65494
- SMILES
- CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
- Canonical SMILES
- CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O
名称与同义词
- Sufentanil citrate
- Sufenta
- Fentatienil
- Zalviso
- Sufentanil (citrate)
- Sufentanyl citrate
- Sufental
- Sufentanil Forte
- Sufentanil TDS
- Sufentanyl Citrat
- Sufentanil citrate cii
- DSUVIA
- Sulfentanil Citrate
- TRANSDUR-Sufentanil
- R 30730 citrate salt
- Sufenta (TN)
- Sufenta Preservative Free
- Dsuvia (TN)
- Sufentanil citrate [USAN]
- SUFENTANILCITRATE
- RefChem:58797
- 60561-17-3
- S9ZFX8403R
- UNII-S9ZFX8403R
- Sufentanil citrate (USP)
- DTXSID5048928
- D01SJC
- Sufentanil Citrate solution
- Sufentanil transdermal patch
- AC1L23CS
- DEA No. 9740
- SCHEMBL41227
- Sufentanil citrate [USAN:USP]
- ARX-F01
- ARX-F02
- DTXCID2028854
- MLS002320668
- C22H30N2O2S.C6H8O7
- EINECS 262-295-4
- OJCZPLDERGDQRJ-UHFFFAOYSA-N
- ARX-01
- ARX-02
- ARX-04
- CHEBI:9317
- SUFENTANIL CITRATE [MI]
- CHEMBL1201163
- DEA NO. 9740 (Citrate)
- HMS2272F05
- SUFENTANIL CITRATE [VANDF]
- SUFENTANIL CITRATE [MART.]
- CID65494
- SUFENTANIL CITRATE [WHO-DD]
- Tox21_112879
- 4074AH
- HY-13754A
- MFCD00072116
- AKOS027325565
- R-33800
- CS-3051
- EN-3270
- R33800
- SUFENTANIL CITRATE [ORANGE BOOK]
- SUFENTANIL CITRATE CII [USP-RS]
- NCGC00247355-02
- SUFENTANIL CITRATE [EP MONOGRAPH]
- R 33800
- SMR001338814
- SUFENTANIL CITRATE [USP MONOGRAPH]
- CAS-60561-17-3
- LS-124419
- NS00076344
- C22-H30-N2-O2-S.C6-H8-O7
- Sufentanil Citrate (100 ug/mL in Methanol)
- D00845
- Sufentanil Citrate (1.0mg/ml in Acetonitrile)
- R-30730
- A1238919
- N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide citrate
- Q27289102
- 2-hydroxypropane-1,2,3-tricarboxylic acid;N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
- N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropionamide citrate
- N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)-N-phenylpropionamide citrate
- N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide citrate (1:1)
- Sufentanil Citrate 0.1 mg/ml in Methanol (as free base)
- Propanamide, N-(4-(methoxymethyl)-1-(2-(thienyl)ethyl)-4-piperidinyl)-N-phenyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Propionanilide, N-(4-(methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)-, citrate
- N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]-N-phenylpropionamide citrate
- N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide citrate (1:1)
- 2-Hydroxypropane-1,2,3-tricarboxylic acid--N-{4-(methoxymethyl)-1-[2-(thiophen-2-yl)ethyl]piperidin-4-yl}-N-phenylpropanamide (1/1)
- 2-hydroxypropane-1,2,3-tricarboxylic acid; N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
- 262-295-4
- N-(4-(methoxymethyl)-1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropionamide citrate
- N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl, propanamide 2-Hydroxy-1,2,3-propanetricarboxylate
- Propanamide, N-(4-(methoxymethyl)-1-(2-(thienyl)ethyl)-4-piperidinyl)-N-phenyl-, 2-hydroxy-1,2,3-propanetricarboxylate(1:1)
- Propanamide, N-[4-(methoxymethyl)-1-[2- (2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Propanamide, N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-, 2-hydroxy-1,2,3-propane tricarboxylate (1:1)
- Sufentanil Citrate solution, 100 mug/mL in methanol (as free base), ampule of 1 mL, certified reference material
- Sufentanil Citrate; N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide 2-hydroxy-1,2,3-propanetricarboxylate (1:1)